Pharmacists Provide Telemedicine in Addition to Clinic Visits to Improve Diabetes Management
Status
Conditions
Treatments
Details and patient eligibility
About
This prospective study will include both an intervention and control arm. The control arm will receive face-to-face pharmacy clinic visits per standard of care. The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up. Patients with a hemoglobin A1c in the last 3 months greater than 9% will be eligible. Eligible patients must have a primary care physician at Johns Hopkins Outpatient Center (JHOC) or East Baltimore Medical Center (EBMC).
Purpose: To compare the change in hemoglobin A1c over the 3 month study period in the intervention group in which patients participate in telemedicine, to a control group in which they do not
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Adult patients with a primary care provider at JHOC or EMBC
- Patients have seen primary care provider within last 6 months
- Patients with hemoglobin A1c greater than 9%
Exclusion criteria
- Patients <18 years of age
- Patients with previously established care with JHH ambulatory care pharmacist
- Patients with communication barriers who do not have a caregiver
- Patients with new diagnosis of diabetes
- Patients who are pregnant or planning to become pregnant during the time of the study
- Patients followed by Endocrinology or Diabetes Center
Trial design
Primary purpose
Allocation
Interventional model
Masking
30 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal